Subcutaneous immunoglobulin replacement following CD19‐specific chimeric antigen receptor T‐cell therapy for B‐cell acute lymphoblastic leukemia in pediatric patients
2018 ◽
Vol 24
(3)
◽
pp. S171-S172
2020 ◽
Vol 16
(10)
◽
pp. 1029-1042
2020 ◽
Vol 105
(2)
◽
pp. 203-215
◽